Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

207
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
207
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

791
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
791

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Growth Differentiation Factor-15 Could Predict Decreased Hemoglobin in Tuberculosis Treated With Linezolid-Containing Regimen.

The clinical respiratory journal·2026
Same author

The ghost of tuberculosis past.

Nature medicine·2026
Same author

Lungs Are Only Half the Story: Programmatic Shifts to Prioritize Pediatric Extrapulmonary Tuberculosis Detection in High-Burden Settings.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis.

Lancet regional health. Americas·2026
Same author

Age and sex differences in paediatric tuberculosis care for child contacts.

Journal of global health·2026
Same author

Diagnostic Performance of New Commercial IGRAs for Mycobacterium tuberculosis Infection: An updated Systematic Review and Meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K

La tuberculosis

Anete Trajman1, Jonathon R Campbell2, Tenzin Kunor3

  • 1Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; McGill International TB Centre, Montreal, QC, Canada.

Lancet (London, England)
|March 8, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La tuberculosis (TB) es una amenaza para la salud mundial. El diagnóstico precoz y la atención integral centrada en la persona, incluida la gestión de los factores de riesgo y las comorbilidades, son cruciales para el tratamiento y la prevención efectivos de esta enfermedad transmitida por el aire.

Más Videos Relacionados

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Videos de Experimentos Relacionados

Last Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Área de la Ciencia:

  • Salud global
  • Enfermedades infecciosas
  • Medicina de las vías respiratorias

Sus antecedentes:

  • La tuberculosis (TB) sigue siendo una causa importante de mortalidad en todo el mundo.
  • La transmisión por vía aérea representa un riesgo para todos, especialmente en las zonas de alta incidencia.
  • La progresión hacia la tuberculosis activa se acelera por factores como la desnutrición, la inmunosupresión y las comorbilidades como la diabetes.

Objetivo del estudio:

  • Revisar el conocimiento actual sobre la transmisión, el diagnóstico, el tratamiento y la prevención de la tuberculosis.
  • Destacar la importancia de la atención centrada en la persona en el tratamiento de la tuberculosis y sus factores de riesgo asociados.
  • Hacer hincapié en la necesidad de una investigación continua en diagnósticos y terapias para la eliminación de la tuberculosis.

Principales métodos:

  • Revisión de la literatura actual sobre la epidemiología de la tuberculosis, la presentación clínica y las estrategias de tratamiento.
  • Análisis de los métodos de diagnóstico, incluido el examen del esputo, las pruebas moleculares y la radiografía torácica.
  • Examen de los regímenes de tratamiento, los métodos de prevención y el papel de la gestión de las comorbilidades y los determinantes sociales.

Principales resultados:

  • El diagnóstico de la tuberculosis requiere un alto índice de sospecha, con una rápida identificación ayudada por pruebas de esputo y radiografía.
  • El tratamiento eficaz consiste en regímenes a corto plazo (≤6 meses) para la tuberculosis susceptible a los medicamentos, con una duración más larga para las formas resistentes a los medicamentos.
  • La atención integral que aborda la desnutrición, el consumo de sustancias y las comorbilidades como la diabetes y el VIH es vital para obtener resultados exitosos y prevenir complicaciones a largo plazo.

Conclusiones:

  • El tratamiento exitoso de la tuberculosis depende del diagnóstico precoz, del tratamiento personalizado y de una atención integral centrada en la persona.
  • Abordar los determinantes sociales y las comorbilidades es esencial para un control y prevención eficaces de la tuberculosis.
  • Los avances en el diagnóstico y la terapia, junto con mejores estrategias de prevención, son fundamentales para lograr la eliminación global de la tuberculosis.